全球牛短暂热疫苗市场研究报告 - 2023 年至 2030 年产业分析、规模、份额、成长、趋势与预测
市场调查报告书
商品编码
1377846

全球牛短暂热疫苗市场研究报告 - 2023 年至 2030 年产业分析、规模、份额、成长、趋势与预测

Global Bovine Ephemeral Fever Vaccines Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: | 出版商: Value Market Research | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

全球牛短暂发烧疫苗市场需求预计将从 2022 年的 72.35 万美元达到 2030 年近 93.02 万美元的市场规模,2023-2030 年研究期间CAGR为 3.19%。

牛短暂热 (BEF),通常也称为三天病,是一种影响牛和水牛的病毒性疾病。 BEF 疫苗是为预防或控制这种疾病而开发的疫苗。

市场动态:

有牛短暂性热爆发历史的地区和疾病流行的地区依靠这些疫苗来保护牛隻和水牛群。这种疾病的经济影响,包括牛奶产量减少和体重减轻,推动了需求,因为农民寻求保护他们的牲畜并保持生产力。政府措施通常涉及疫苗接种计划,以控制和预防牛短暂热病的爆发,从而进一步促进疫苗的使用。牲畜贸易的全球化扩大了市场,涵盖了以前未受该疾病影响的地区。持续的研究和开发工作增强了疫苗配方和递送方法,使其对生产者和使用者更具吸引力。提高意识、教育活动和监管批准进一步支持疫苗接种实践。环境因素和昆虫媒介控制也会影响牛短暂热病的爆发,可能会增加对疫苗的需求。随着研究、技术的进步和疾病动态的变化,牛短暂热疫苗市场不断发展,确保其在保护全球牛和水牛种群方面的相关性。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外,这些工具也对全球牛短暂热疫苗市场的各个细分市场进行了包容性评估。牛短暂热疫苗产业的成长和趋势为本研究提供了整体方法。

区域分析:

本节涵盖区域前景,重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲牛短暂发烧疫苗市场当前和未来的需求。此外,该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。牛短暂热疫苗市场的主要参与者包括 Zoetis Inc、Onderstepoort Biological Products SOC Ltd、Green Cross Veterinary Products Co Ltd、兽医血清和疫苗研究所以及 CAVAC(ChoongAng Vaccine Laboratories Co Ltd)。 ,例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求,请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章:前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法论
    • 市场研究过程
    • 市场研究方法论

第 2 章:执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章:牛短暂性发烧疫苗 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按类型分類的市场吸引力分析
    • 市场吸引力分析:依应用分类
    • 最终用户的市场吸引力分析
    • 市场吸引力分析:按地区

第 4 章:价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章:全球牛短暂性发烧疫苗市场分析:按类型

  • 按类型概述
  • 历史和预测数据
  • 按类型分析
  • 活疫苗
  • 灭活疫苗
  • 其他的

第 6 章:全球牛短暂性发烧疫苗市场分析:依应用分类

  • 概述:按应用
  • 历史和预测数据
  • 分析:按应用
  • 水牛

第 7 章:全球牛短暂性发烧疫苗市场分析:依最终用户分类

  • 最终用户概述
  • 历史和预测数据
  • 最终用户分析
  • 医疗器材公司
  • 製药业
  • 动物医院
  • 其他

第 8 章:全球牛短暂性发烧疫苗市场分析:依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区国家/地区销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 9 章:牛短暂性发烧疫苗公司的竞争格局

  • 牛短暂性发烧疫苗市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 10 章:公司简介

  • 公司股份分析
  • 市场集中度
  • Zoetis Inc
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Onderstepoort Biological Products SOC Ltd
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Green Cross Veterinary Products Co Ltd
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Veterinary Serum & Vaccine Research Institute
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • CAVAC ChoongAng Vaccine Laboratories Co Ltd
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展

注意 - 在公司概况中,财务详细资讯和近期发展视情况而定,或者如果是私人公司,则可能不包括在内

Product Code: VMR112112314

The global demand for Bovine Ephemeral Fever Vaccines Market is presumed to reach the market size of nearly USD 93.02 MN by 2030 from USD 72.35 MN in 2022 with a CAGR of 3.19% under the study period 2023 - 2030.

Bovine ephemeral fever (BEF), also commonly referred to as three-day sickness, is a viral illness that impacts cattle and water buffalo. BEF vaccines are vaccines developed to prevent or control this disease.

MARKET DYNAMICS:

Regions with a history of bovine ephemeral fever outbreaks and areas where the disease is endemic rely on these vaccines to protect cattle and water buffalo herds. The economic impact of this disease, including reduced milk production and weight loss, drives demand as farmers seek to safeguard their livestock and maintain productivity. Government initiatives often involve vaccination programs to control and prevent bovine ephemeral fever outbreaks, further promoting vaccine use. The globalization of livestock trade has expanded the market, reaching regions previously unaffected by the disease. Ongoing research and development efforts enhance vaccine formulations and delivery methods, making them more attractive to producers and users. Increasing awareness, education campaigns, and regulatory approvals further support vaccination practices. Environmental factors and insect vector control also impact bovine ephemeral fever outbreaks, potentially increasing the need for vaccines. The bovine ephemeral fever vaccine market continues to evolve with advancements in research, technology, and changing disease dynamics, ensuring its relevance in protecting cattle and water buffalo populations globally.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of bovine ephemeral fever vaccines. The growth and trends of bovine ephemeral fever vaccines industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the bovine ephemeral fever vaccines market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Live Vaccine
  • Killed Vaccine
  • Others

By Application

  • Cattle
  • Water Buffaloes

By End-User

  • Medical Device Companies
  • Pharmaceutical Industries
  • Animal Hospitals
  • Other

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Bovine Ephemeral Fever Vaccines market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Bovine Ephemeral Fever Vaccines market include Zoetis Inc, Onderstepoort Biological Products SOC Ltd, Green Cross Veterinary Products Co Ltd, Veterinary Serum & Vaccine Research Institute and CAVAC (ChoongAng Vaccine Laboratories Co Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . BOVINE EPHEMERAL FEVER VACCINES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By End-User
    • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL BOVINE EPHEMERAL FEVER VACCINES MARKET ANALYSIS BY TYPE

  • 5.1 Overview by Type
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Type
  • 5.4 Live Vaccine Historic and Forecast Sales by Regions
  • 5.5 Killed Vaccine Historic and Forecast Sales by Regions
  • 5.6 Others Historic and Forecast Sales by Regions

6 . GLOBAL BOVINE EPHEMERAL FEVER VACCINES MARKET ANALYSIS BY APPLICATION

  • 6.1 Overview by Application
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Application
  • 6.4 Cattle Historic and Forecast Sales by Regions
  • 6.5 Water Buffaloes Historic and Forecast Sales by Regions

7 . GLOBAL BOVINE EPHEMERAL FEVER VACCINES MARKET ANALYSIS BY END-USER

  • 7.1 Overview by End-User
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by End-User
  • 7.4 Medical Device Companies Historic and Forecast Sales by Regions
  • 7.5 Pharmaceutical Industries Historic and Forecast Sales by Regions
  • 7.6 Animal hospitals Historic and Forecast Sales by Regions
  • 7.7 Other Historic and Forecast Sales by Regions

8 . GLOBAL BOVINE EPHEMERAL FEVER VACCINES MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2. North America By Segment Sales Analysis
    • 8.3.3. North America By Country Sales Analysis
    • 8.3.4. United State Sales Analysis
    • 8.3.5. Canada Sales Analysis
    • 8.3.6. Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2. Europe by Segment Sales Analysis
    • 8.4.3. Europe by Country Sales Analysis
    • 8.4.4. United Kingdom Sales Analysis
    • 8.4.5. France Sales Analysis
    • 8.4.6. Germany Sales Analysis
    • 8.4.7. Italy Sales Analysis
    • 8.4.8. Russia Sales Analysis
    • 8.4.9. Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2. Asia Pacific by Segment Sales Analysis
    • 8.5.3. Asia Pacific by Country Sales Analysis
    • 8.5.4. China Sales Analysis
    • 8.5.5. India Sales Analysis
    • 8.5.6. Japan Sales Analysis
    • 8.5.7. South Korea Sales Analysis
    • 8.5.8. Australia Sales Analysis
    • 8.5.9. South East Asia Sales Analysis
    • 8.5.10. Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2. Latin America by Segment Sales Analysis
    • 8.6.3. Latin America by Country Sales Analysis
    • 8.6.4. Brazil Sales Analysis
    • 8.6.5. Argentina Sales Analysis
    • 8.6.6. Peru Sales Analysis
    • 8.6.7. Chile Sales Analysis
    • 8.6.8. Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2. Middle East & Africa by Segment Sales Analysis
    • 8.7.3. Middle East & Africa by Country Sales Analysis
    • 8.7.4. Saudi Arabia Sales Analysis
    • 8.7.5. UAE Sales Analysis
    • 8.7.6. Israel Sales Analysis
    • 8.7.7. South Africa Sales Analysis
    • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE BOVINE EPHEMERAL FEVER VACCINES COMPANIES

  • 9.1. Bovine Ephemeral Fever Vaccines Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF BOVINE EPHEMERAL FEVER VACCINES INDUSTRY

  • 10.1. Company Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Zoetis Inc
    • 10.3.1. Company Overview
    • 10.3.2. Company Revenue
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. Onderstepoort Biological Products SOC Ltd
    • 10.4.1. Company Overview
    • 10.4.2. Company Revenue
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. Green Cross Veterinary Products Co Ltd
    • 10.5.1. Company Overview
    • 10.5.2. Company Revenue
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. Veterinary Serum & Vaccine Research Institute
    • 10.6.1. Company Overview
    • 10.6.2. Company Revenue
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. CAVAC ChoongAng Vaccine Laboratories Co Ltd
    • 10.7.1. Company Overview
    • 10.7.2. Company Revenue
    • 10.7.3. Products
    • 10.7.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Type (USD MN)
  • Live Vaccine Market Sales by Geography (USD MN)
  • Killed Vaccine Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis Market by Application (USD MN)
  • Cattle Market Sales by Geography (USD MN)
  • Water Buffaloes Market Sales by Geography (USD MN)
  • Analysis by End-User (USD MN)
  • Medical Device Companies Market Sales by Geography (USD MN)
  • Pharmaceutical Industries Market Sales by Geography (USD MN)
  • Animal hospitals Market Sales by Geography (USD MN)
  • Other Market Sales by Geography (USD MN)
  • Global Bovine Ephemeral Fever Vaccines Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Bovine Ephemeral Fever Vaccines Report
  • Market Research Process
  • Market Research Methodology
  • Global Bovine Ephemeral Fever Vaccines Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by End-User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Type (USD MN)
  • Live Vaccine Market Sales by Geography (USD MN)
  • Killed Vaccine Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Cattle Market Sales by Geography (USD MN)
  • Water Buffaloes Market Sales by Geography (USD MN)
  • Global Market Analysis by End-User (USD MN)
  • Medical Device Companies Market Sales by Geography (USD MN)
  • Pharmaceutical Industries Market Sales by Geography (USD MN)
  • Animal hospitals Market Sales by Geography (USD MN)
  • Other Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.